Lead annual budgeting, quarterly forecasting, multi-year strategic planning processes; develop/and maintain forecasting methodologies/assumption frameworks appropriate to clinical-stage biotechnology environment where program assumptions evolve continuously; develop liquidity forecasting/cash runway analyses/long-range operating forecasts for pre-revenue companies using historical operating data/changing operational assumptions (MS Excel financial modeling); translate clinical/manufacturing operations (timelines, milestone progression, licensing assumptions) for structured financial forecasting/scenario-planning; build complex models Discounted Cash Flow (DCF) valuation , licensing structures; evaluate biotech, healthcare, life sciences, emerging technology entities (clinical-stage operating models, R&D-intensive cost structures); design/maintain integrated financial model combining historical actuals, operating budget, multi-year strategic forecast within driver-based architecture; develop specialized forecasting modules; translate scientific, clinical, manufacturing, operational inputs into financial decision models (assumptions for clinical trial activities, natural history study operations, dosing protocols, manufacturing costs, licensing scenarios); monitor forecast-to-actual variance; refine assumptions; improve forecast accuracy; develop/maintain long-range financial forecast/DCF valuation models; support strategic planning, investor communications, capital allocation decisions; validate revenue assumptions through independent market research (patient population sizing, pricing proxies, market penetration assumptions, uptake scenarios); support cash runway planning through multi-year cash flow forecasting, cash balance roll-forward, liquidity impact assessment; conduct scenario/sensitivity analyses evaluating impact of operating spend changes, clinical expansion, licensing decisions, strategic alternatives on projected cash position; build financial models to evaluate return/strategic implications of potential licensing transactions; and support development of commercialization-related financial assumptions (market benchmarks, patient population modeling, pricing proxies, uptake scenarios as company's programs advance toward potential commercial launch). This is a telecommuting position with remote benefit from various unanticipated locations throughout the U.S. Job Requirements: Masters degree or foreign equivalent in Business Administration or Finance plus 2 years experience. Experience to include developing liquidity forecasting/cash runway analyses/long-range operating forecasts for pre-revenue companies using historical operating data/changing operational assumptions (MS Excel financial modeling); translating clinical/manufacturing operations (timelines, milestone progression, licensing assumptions) for structured financial forecasting/scenario-planning; building complex models Discounted Cash Flow (DCF) valuation , licensing structures; and evaluating biotech, healthcare, life sciences, emerging technology entities (clinical-stage operating models, R&D-intensive cost structures). This is a telecommuting position with remote benefit from various unanticipated locations throughout the U.S. Salary range from $95,493 to $135,000 per year.
Not specified in the original listing.
Not specified in the original listing.
